TIAN RUIXIANG Holdings Ltd. Announces Receipt of Nasdaq Suspension and Delisting Notification
MWN-AI** Summary
TIAN RUIXIANG Holdings Ltd. (Nasdaq: TIRX) has announced that it received a notification from Nasdaq regarding the suspension and potential delisting of its securities due to its stock price falling below $0.10 for ten consecutive trading days, in accordance with the “Low Priced Stocks Rule” under Listing Rule 5810(c)(3)(A)(iii). This notification marks a significant challenge for the company, as it faces the potential removal of its shares from the Nasdaq Stock Market.
Effective March 5, 2026, trading of TIRX shares will be suspended, and the company will file a Form 25-NSE with the Securities and Exchange Commission (SEC) to formalize the delisting process. However, TIAN RUIXIANG has the opportunity to present its case to the Nasdaq Hearings Panel by March 10, 2026, and is actively seeking to appeal for a temporary cessation of the suspension or for reinstatement of its trading status.
In an effort to combat these challenges, the company is currently implementing a reverse stock split of its ordinary shares at a ratio of 1-for-50, a strategy aimed at boosting its share price and improving compliance with listing requirements.
Operating from Beijing, TIAN RUIXIANG Holdings Ltd. is an insurance broker focused on distributing a diverse array of insurance products, which include property, casualty, health, and life insurance. The company cautions that any forward-looking statements regarding its future plans are subject to various risks and uncertainties, and there is no guarantee of a favorable outcome from the ongoing discussions with Nasdaq. The outcome of this situation may significantly impact the company’s market presence and investor sentiment moving forward.
MWN-AI** Analysis
TIAN RUIXIANG Holdings Ltd. (Nasdaq: TIRX) has encountered significant turbulence, as evidenced by its recent notification from Nasdaq regarding potential delisting due to its stock plummeting to a bid price of $0.10 or less for ten consecutive trading days. This triggered provisions under Listing Rule 5810(c)(3)(A)(iii), along with the suspension of trading set for March 5, 2026. Given these developments, investors should approach TIRX with caution amidst uncertainty about the company’s future on the Nasdaq Capital Market.
The company's management is attempting to appeal the suspension and justify an ongoing listing. They plan to submit their arguments by March 10, 2026, but there is no assurance that the appeal will succeed. Additionally, TIRX is implementing a 1-for-50 reverse stock split, a move typically aimed at boosting a company's stock price by consolidating shares. While this may generate short-term price appreciation, it does not inherently resolve underlying operational or financial issues.
From an investment perspective, potential buyers should carefully assess the risk-reward profile of TIRX. The significant price drop suggests a loss of investor confidence and could indicate deeper financial challenges within the company, particularly in the competitive and rapidly evolving insurance brokerage industry in China. While the potential for recovery exists, it would likely require a robust turnaround strategy and a favorable reception from Nasdaq's Hearings Panel.
For investors currently holding TIRX shares, monitoring the company's response to Nasdaq and its performance post-reverse split will be critical. A proactive stance is advised, as further delisting could lead to substantial losses. In such a volatile environment, maintaining a diversified portfolio and seeking opportunities in more stable sectors may mitigate the risks associated with TIRX.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
BEIJING, March 04, 2026 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (Nasdaq: TIRX) (the “Company” or “TRX”) today announced that it received notification from Nasdaq Staff which determined that as of February 27, 2026, the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”) and this matter serves as an additional basis for delisting the Company’s securities from The Nasdaq Stock Market.
Pursuant to Listing Rule 5815(a)(1)(B)(ii)(e), the Company’s securities will be delisted from the Capital Market. In that regard, trading of the Company’s shares will be suspended at the opening of business on March 5, 2026, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market.
The Nasdaq Hearings Panel (the “Panel”) will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market. The Company is able to present its views with respect to this additional deficiency to the Panel in writing no later than March 10, 2026.
The Company is currently working together with its advisors to appeal for a stay of the suspension of trading of its securities on Nasdaq or reinstate such trading as soon as possible. The Company will submit its response to Nasdaq prior to the March 10, 2026 deadline. There is no guarantee that the Company will be able to stay such suspension or reinstate such trading, or that the Company’s shares will remain listed on Nasdaq. The Company is presently in the process of implementing the 1-for-50 reverse stock split (the “Reverse Split”) of its ordinary shares.
About TIAN RUIXIANG Holdings Ltd
TIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker operating in China through its China-based variable interest entity. It distributes a wide range of insurance products, which are categorized into two major groups: (1) property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and (2) other types of insurance, such as health insurance, life insurance, and other miscellaneous insurance.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These include statements regarding future plans, objectives, expectations and intentions, and involve known and unknown risks and uncertainties. Words such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “continue,” or similar expressions identify these statements. These forward-looking statements are based on current expectations and assumptions and are not guarantees of future performance; actual results may differ materially. TIAN RUIXIANG Holdings Ltd. undertakes no obligation to update these statements for subsequent events or circumstances, except as required by law.
For investor and media enquiries, please contact:
TIAN RUIXIANG Holdings Ltd
Investor Relations Department
Email: ir@tianrx.com
FAQ**
What specific actions is TIAN RUIXIANG Holdings Ltd TIRX taking to address the Nasdaq delisting notification and improve its stock price above the $0.threshold?
How will the implementation of the 1-for-50 reverse stock split affect investor perception and trading volume for TIAN RUIXIANG Holdings Ltd TIRX in the short term?
What are the potential implications for TIAN RUIXIANG Holdings Ltd TIRX if the appeal for a stay of the suspension is unsuccessful?
In light of the announcement, what steps is TIAN RUIXIANG Holdings Ltd TIRX taking to enhance its overall financial performance and increase shareholder value?
**MWN-AI FAQ is based on asking OpenAI questions about TIAN RUIXIANG Holdings Ltd (NASDAQ: TIRX).
NASDAQ: TIRX
TIRX Trading
-36.78% G/L:
$0.0373 Last:
19,119,140 Volume:
$0.0517 Open:
